The effects of lobbying on the FDA’s recall classification
Abstract Background The US Food and Drug Administration (FDA) regulates goods accounting for 20% of US consumers’ total expenditure. The agency’s potential susceptibility to corporate lobbying and political influence may adversely affect the its abilities to fulfill its duties as a vital federal age...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2023-06-01
|
| Seri Bilgileri: | BMC Medical Ethics |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12910-023-00921-0 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|